Introduction
============

Bicuspid aortic valve (BAV) disease has the characteristic of heredity with variable genetic penetrance. And 0.5--2% of the population worldwide have the possibility to be attacked by this disease, which 75% of them are male ([@B25]; [@B84]). Initially, most children with BAV disease are asymptomatic and not aware of its presence, resulting in complications which are presented in adulthood. Accurate diagnosis at early stage and effective intervention are essential to prevent various complications. Nature history of patients with surgery is not same as normal ones, therefore continued surveillance and personalized surgical therapy are required. Although a series of studies have introduced some aspects of BAV including etiology, rheology, morphology and genetics, questions are still unanswered ([@B90]). This review provides a brief introduction of morphology characteristics, recent advances on genetic and biomarkers, and update in imaging diagnosis and recommendations for the treatment of BAV disease.

Morphology: Different Classification Endow Different Effects
============================================================

The typical structure of the aortic valve had three semilunar leaflets in shape. Due to the fusion of two cusps out of three, BAV usually included two unequal cusps and a central raphe.

From a surgical point of view, Sievers classification system was used widely in [Figure 1A](#F1){ref-type="fig"} ([@B131]). Based on number of raphes, three categories of BAV are presented in patients including type 0 (no raphe in the valve), type 1 (only one raphe in the valve) and type 2 (two raphes in the valve). And the most common type is type 1, which accounting for about 90% of the patients ([@B133]). On the basis of the raphe position with coronary sinuses, types 1 and 2 were classified as left (L), right (R) and none (N) type. The right and left coronary leaflet (RL) were most common accounted for about 80%, the right and non-coronary leaflet (RN) was about 17% and left and non-coronary leaflet (LN) was 2%. Compared to Asians, type 0 BAV was more frequently among Europeans, whereas the incidence of RN-BAV with a raphe was higher in Asian ([@B74]). Aortic stiffness was measured by pulse wave velocity (PWV) using velocity-encoded magnetic resonance imaging (VENC-MRI) and patients with R-NC fusion were manifested as greater PWV than patients with R-L fusion phenotype. This assessment might be a novel parameter to evaluate surgical risk ([@B15]).

![Schematic diagram and images of different bicuspid aortic valve morphology. The Sievers classification and echocardiographic images are shown in **(A)**. Dichotomous classification is shown in **(B)**. Red bands and arrows represent the raphe or commissural fusion. Red dotted lines represent that patients with BAV has the fusion of the non-coronary cusp with the right coronary cusp or the left coronary cusp but it is hard to demonstrate raphe to adequately classify the subtype. The ostium of right coronary artery (RCA) is depicted on the left and the left main (LM) is on the right (**A** used with permission).](fphys-09-01921-g001){#F1}

In order to show the relationship between BAV morphology type and valvulopathy or aortopathy, the dichotomous classification method was introduced in [Figure 1B](#F1){ref-type="fig"}. The right and left coronary leaflet cusp fusion was defined as the coronary cusp fusion (CCF) and all other types were defined as the mixed cusp fusion (MCF). The MCF type of BAV was considered as one of risk factors for the occurrence of aortic stenosis and associated aortopathy, which resulted in significant hemodynamic changes. Transthoracic echocardiography (TTE) imaging that has characteristics of accuracy and feasibility makes this classification be a valuable approach in routine use ([@B63]; [@B137]).

Transthoracic echocardiography was the preferred method for the diagnosis of valvular status in BAV patients. The classical shape, "fish-mouth," was appeared in the views of short-axis when the valve was step into systole. And the view of long-axis might also provide some abnormal manifestations of bicuspid valve in systole ([@B78]). TTE alone, however, is hard to determine presence/absence of raphe or position of the orifice of the coronary artery. TTE could identify valvular phenotype in 47.4% patients and 2D TEE might achieved to 90.1%. But, 2D TEE images was hard to provide the precise phenotype in 9.9% BAV patients, where 3D TEE was effective. In patients who had short raphe or disappearance of the raphe due to calcification in aortic leaflets, 3D TEE might excel in providing important features about valve structure in experienced hands ([@B155]). And another imaging method, color doppler, is a useful tool to identify immobile trileaflet aortic valves or bicuspid valve by commissural fusion ([@B78]).

In order to preferable evaluate the aortic valve, the anatomy of aortic root especially the three-dimensional anatomy must be comprehended intensively. The aortic root is consisted of three distinct entities, including the sino-tubular junction (STJ), aortic sinus and the annulus. The aortic sinus contains the leaflets of aortic valve, the attachments of the leaflet, the sinuses of Valsalva and inter leaflet trigones. The annulus encompasses basal ring, the surgical annulus and the anatomical ventriculo-aortic junction (VAJ). The basal ring, an elliptical shape ring, is defined as a ring with three anchors at the bottom of each attachments of aortic cusps and calcification makes its shape non-homogenous. The surgical annulus, straddling the entire aortic root lengthwise from basal ring to STJ, is characterized as a complex three-dimensional crown-shaped structure, which the lowest parts are nadirs of the sinuses of Valsalva, and the highest ones are the commissures ([@B73]). The ventriculo-aortic junction (VAJ) is a circle which is positioned slightly above the basal ring between the aortic wall and left ventricular myocardium. Patients who received the aortic valve repair, the mean diameter of VAJ in tricuspid exceeding 26 mm and the mean diameter of VAJ in bicuspid valve exceeding 28 mm are defined as relative VAJ enlargement ([@B27]).

The functional aortic annulus (FAA) which seems as elliptical was surrounded by VAJ and STJ at the aortic root. In order to interpretation the different dilatation in all FAA, [@B34] recommended the classification of FAA which aimed to recognize different type of aortic regurgitation. In clinical, the most common phenotypes in BAV repair are El Khoury types Ib and II, which based on Sievers type 1 L-R BAV ([@B8]). Type-IB AR is caused by sinuses of Valsalva dilatation which is excised and replaced with the help of reimplantation or the remodeling technique. Type-II AR is secondary to excessive cusp or commissural disruption, which is corrected with interrupted sub-commissural annuloplasty plication sutures ([@B34]). It is suggested that three dimensions transesophageal echocardiography (3D TEE) and multidetector computed axial tomography (MDCT) were effective in evaluating FAA and most important of all, MDCT is recommend as a criterion imaging technique used to device sizing in the operation of TAVR ([@B64]). CT area possessed the highest correlation and the best agreement with intraoperative sizing, which leading 84.6 and 74.0% of BAVs to agree for theoretical surgical with TAVR prosthesis selection ([@B115]). Through 3DTEE could be used as an alternative for CT in BAVs patients who unsuitable for CT, it still need to be paid more attention especially in patients with aortic annulus calcification because inaccuracy could be caused by partial acoustic shadowing ([@B146]).

In the era of TAVR, it is important to understand the aortic root anatomy precisely, which is the basis for device development, selection and implantation. In BAV patients, the sizes of annulus, sinus of Valsalva and ascending aorta have been enlarged. Traditionally, exclusion diagnosis is the standard diagnostic method for BAV because of asymmetric aortic annulus. This anatomical feature might cause leaflet malformation, even para-valvular leak due to asymmetric deformation and expansion of the rounded bioprosthesis ([@B165]). However, the larger annulus of BAV seems to be a circle and could be suitable for current commercial valved stents ([@B117]).

Sizing the aortic valve annulus that is representing the tightest section of aortic root based on the anatomy, which is suggested to be a valuable method in selecting the size of transcatheter heart valve (THV). The morphological characteristics of supra-annulus that is a scope locating from annulus to the STJ is becoming significantly complex when bicuspid AS combines with severe calcification in leaflets. Annulus measurements using CT might be inaccurate because the definition of the annulus plane derive from two hinge points of the leaflet. The supra-annular structure might have great effects on anchoring THV. Patients who have been diagnosed BAV manifest as morphological changes in valve including annular eccentricity, asymmetrical calcified leaflet, presenting different sizes of leaflets, and following by aortopathy, which increases the possibilities of deeper implantation, PVL, TAV-in-TAV, annulus rupture, aortic dissection ([@B167]). Though CT have advantages in providing anatomic aortic root information, the mechanical characteristics of the annulus or supra-annular structure for THV anchoring could not be revealed completely. However, Balloon sizing, not descripted before, could provide the information about supra-annular mechanical characteristics through the sign of balloon waist combination with contrast aortogram and AR evaluation ([@B81]).

It is critical to select appropriate valve size after TAVI, which could promote rehabilitation. As a valid compensation for multimodality imaging, Balloon sizing has its own characteristics. Although there is smaller anticipated sizing ratio, the incidence of PAR after valve deployment and short-term follow-up does not increase after switching to smaller THV with balloon sizing. With the help of MSCT, patients with smaller valves possessed better stent frame expansion at inflow and a trend toward better frame geometry in terms of circularity than those who received valves of the same size or larger. Although MSCT has extraordinary effect in THV size selecting, balloon sizing could be used as a complementary tool as well as for BAV morphology assessment ([@B153]).

Early repair failure is associated with failure to address the functional aortic annulus in the process of BAV repairment. The deep anterior dissection technique not only avert the problem, but also acquires another goals including making the annuloplasty ring surrounded by the basal ring, permitting to symmetrical implantation, making the tissues of the root anteriorly become thin, causing less muscle bands and improving the accuracy of grafting sizing and matching and preventing recurrence of dilatation in the same area and prolapse of conjoined cusp by IVS ([@B100]).

However, we speculated that aortic valve annulus eccentricity might be innate in infant and early child period. Children who manifest as severe or critical aortic stenosis usually are treated with aortic balloon valvuloplasty, rather than transcatheter AV replacements. 2D angiographic examination of parasternal long axis could assess the size of the aortic valve annulus in pediatric patients at present. The incidence of aortic insufficiency is increasing, as well as residual stenosis, when the size of eccentric annulus is inaccuracy. We suggest that aortic ballon valvuloplasty might help with therapeutic effects when taking the different annular size into account ([@B19]).

Genetics: Polymorphism and Complexity of the Pathogenesis
=========================================================

It is well known that the genetic etiologies of BAV have the characteristic of diversity, which has the same characteristic with BAV phenotypes. BAV was an autosomal-dominant disease and had a highly heritable trait which was up to 89% ([@B44]). Several investigators had shed light upon the mechanism induced by gene mutation in the development of BAV. NOTCH1 mutations were highly penetrant (75%), most of which were BAV ([@B69]). NOTCH1 combined with different ligands at different stages of morphogenetic processes to express variant regulatory effects. Delta-like 4 (Dll4), one of NOTCH ligand, was necessary for epithelial-to-mesenchyme transition formation, and endocardial Jag1-NOTCH1 signaling was essential for later morphogenesis and regulation of mesenchyme proliferation in post epithelial-to-mesenchyme transition ([@B86]). Additionally, NOTCH1 could affect calcium deposition through inhibition Runx2 activation. In the shear stress condition, NOTCH1 haploinsufficiency led to calcification of endocardial cells by dysregulating the downstream transcription of genes, inflammation, oxidative stress and aberrant upregulating pro-calcific nodes ([@B141]). It has been reported that endothelial progenitor cells (EPC) played a critical role in vascular repair processes during stress and development of aortic aneurysms. Compared with TAV patients, the expression level of Notch gene in tissue and circulation was significantly reduced in BAV patients, which directly reduced circulating EPC number, either in presence or absence of ascending aortic aneurysm ([@B4]).

The GATA family is a class of zinc finger proteins. The sub-group, GATA5, was a transcription factor, which was expressed in an overlapping together with GATA4 and GATA6 ([@B111]). The fusion of aortic valve in GATA5 deletion mice was presented in posterior intercalated cushion and septal ridge, resulting in RN BAV. Hence, the effect of GATA5 mutation might be more important in RN type BAV patients ([@B77]). GATA4 was critical for heart differentiation. Two genetic variants have been identified that approached even achieved to genome-wide levels. The rs6601627, representing a low-frequency intergenic variant, has a higher incidence rate in BAV patients. The rs3729856 variant was associated with protein expression, which involved in specific gene transcription in cardiac ([@B157]). GATA6, another GATA family member, might be a novel BAV causing gene. GATA6 heterozygous mice had highly penetrant RL type BAV, the most common type in human. GATA6 haploinsufficiency undermined valve remodeling and extracellular matrix composition through dysregulation of important signaling molecules including matrix metalloproteinase 9. Defective valve remodeling due to dysregulated extracellular matrix degradation has been suggested to be potential mechanism in BAV formation ([@B95]). But common variants at the GATA6 locus associated with BAV were unclear. Of note, although the relation between GATA6 and BAV in human has not been illuminated, the prevalence of BAV is greater in male GATA6+/- mice than female ([@B47]).

Other mutated gene often correlated with specific features and prognosis. Due to abnormal flow in BAV aneurysm, the aberrant methylation of epithelial-mesenchymal-transition and increased expression of WNT/β-catenin genes like MYLK, ZEB1 were involved ([@B12]). Besides, transcriptome analyses and immunohistochemical study of ascending aortic specimens from BAV patients showed that receptor tyrosine kinase (RTK)/p-AKT pathway in the middle part of ascending aortic wall was activated, in spite of the constant expression level of total AKT ([@B55]; [@B156]). Mutations in ACTA2, FBN1, and TGFBR2 genes might be the reason of BAVs with thoracic aortic aneurysm ([@B49]). Two new aortic valve stenosis loci, named rs7543130 on chromosome 1p21 near PALMD or rs1830321 on chromosome 2q22 in TEX41, might be involved in the development of BAV. Rs7543130 associated with BAV and aortic root diameter, and rs1830321 associated with BAV and coronary artery disease ([@B54]). Genetic mutations above determining bicuspid aortic valve are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Main genetic mutations determining bicuspid aortic valve.

  Gene                         Mechanism                                                                                                       Reference
  ---------------------------- --------------------------------------------------------------------------------------------------------------- -----------------------------
  NOTCH 1                      Affect epithelial-to-mesenchyme transition formation and calcium deposition and reduce circulating EPC number   [@B141];[@B69];[@B86];[@B4]
  GATA 5                       Associated with RN BAV formation                                                                                [@B77]
  GATA 4                       Impair endothelial-to-mesenchymal transition                                                                    [@B157]
  GATA 6                       Undermine valve remodeling and EMC by dysregulation of MMP9                                                     [@B95]
  ACTA2, FBN1, TGFBR2          Involved in thoracic aortic aneurysm caused by BAV, Marfan syndrome, Loeys-Dietz syndrome                       [@B49]
  WNT/β-catenin or RTK/p-AKT   Aberrant signaling pathway involved in BAV ascending aortic and aneurysm                                        [@B55];[@B156]
  New loci on chromosome                                                                                                                       
  1p21 near rs7543130          Associated with increased aortic root size in BAV                                                               [@B54]
  2q22 in rs1830321            Associated with BAV and coronary artery disease                                                                 

Biomarkers of BAV: Prospective in Diagnosis and Treatment
=========================================================

Although BAV is a hereditary disease and most BAV patients are asymptomatic at onset, we still hope to explore some molecular biological markers to speculate the progression of BAV. Matrix metalloproteinase (MMP) would affect degradation of extracellular matrix proteins such as elastin and collagen in the aortic wall ([@B118]). The increased MMP-2 level in circulation could predict the ascending aortic dilation in BAV patients independently without significant valvular dysfunction ([@B148]; [@B147]). TGF-β and its receptor ENG correlated with the severity of the development of aortic dilation in bicuspid aortic stenosis patients. The signaling pathway played a vital role in fibrosis, inflammation and extracellular matrix of cardiovascular system. There might be a relationship between TGF-β1/ENG ratio and aortic diameter. When aortic diameter \<45 mm, the ratio becomes higher and abnormal aortic wall remodeling comes even more severer with increasing expression of MMP-2 and TGF-β as well as decreasing expression of superoxide dismutase 3. And, the ratio has positive correlation with the rate of ascending aortic growth in AVR postoperative period of bicuspid aortic stenosis patients. Therefore, the ratio of TGF-β1/ENG might be a novel predictor for the risk and severity of BAV aortopathy ([@B42]). However, the development of aneurysms in patients with BAV was not associated with an increased TGFβ activity ([@B113]). In stenotic aortic leaflets from BAV patients compared with TAVs, the downregulation of miR-195 was associated with accelerated valvular calcification via targeting SMAD7, which involved the progress of fibrosis and remodeling of the extracellular matrix ([@B31]). In addition, miR-17 could indicate different part of aorta dilation by regulating expression of TIMP1/2 and MMP2. In normal aorta, the expression of miR-17 and related miRNAs was low. And the level of TIMP1/2 was normal, inhibiting MMP2 activity. During the early phase of BAV-associated dilation, miR-17 was upregulated, inhibiting TIMP1/2, which subsequently increased MMP-2 activity, leading to progressive extracellular matrix breakdown, aortic dilation and aneurysm formation. Once severe tissue dilation had occurred, miR-17 expression was reduced, TIMP1/2 expression increased, and MMP-2 activity decreased toward baseline levels ([@B152]). The expression of proteins and miRNAs might be a potential prognostic biomarker for predicting pathological aorta in BAV patients. Optimal therapies targeted at different proteins and miRNAs were not only novel treatments of aortic complications in BAV patients, but also preventing early stages of disease development before irreversible valve calcification, aorta became dilated severely and aortic aneurysm was formed aggressively. To date, the research about biomarkers that was used to early diagnose BAV clinically is still at its infancy. However, the truth on those markers has not been uncovered. And further investigations in large patient cohorts are needed to provide strong data.

BAV Associated Complications: the Supplement for Guideline Diagnosis and Treatment
==================================================================================

The BAV was not only just a valve disease, but also it was related to secondary aortic stenosis, aortic insufficiency, infective endocarditis and cardiac dysfunction. Due to the influence in gene and abnormal aortic blood flow, BAV patients would suffer from ascending aortic dilated and aneurysm. So far, the most strategic therapy is operation at appropriate time and prevent complications. In this part, we provide a brief introduction and supplement of diagnose and treatment for BAV.

Bicuspid Valvulopathy: a Complication With High Incidence and Induced Left Ventricle Dysfunction Need to Pay More Attention
===========================================================================================================================

A recent report about prevalence and complications of BAV in Chinese, suggested that almost half of the patients who were diagnosed BAV had different degrees of aortic valve disease with similar results in western report ([@B80]; [@B90]). In the large international registry of 2118 patients with BAV, compared with patients with raphe, the prevalence of aortic stenosis and aortic regurgitation was lower in patients who have no raphe. The 2 raphes was associated with higher prevalence of significant aortic stenosis and regurgitation compared with the 1 raphe. Among patients with 1 raphe, RN-BAVs had more aortic stenosis. Due to valvular dysfunction at a younger age, BAV patients with raphe prefer to perform AVR, but not related with an increased risk for all-cause mortality ([@B75]).

Aortic Stenosis: Multiple Imaging Technology Evaluation
=======================================================

As one of major risk factors, BAV was involved in mild to severe AS. TTE has been recommended in bicuspid aortic valve patients with symptoms. It could provide precise diagnosis of abnormal hemodynamic and left ventricle function. And, TTE might be used to decide the surgical intervention time and speculate prognosis ([@B104]). TTE derived left ventricular outflow tract (LVOT) area might be inaccurate because of single diameter of elliptical aortic root. Compared with the aortic valve area-ECHO (AVA ECHO), the AVA CT (aortic valve area was calculated by MDCT) was larger overall in BAVs, but could not show the relation to transvalvular gradient, the concordance gradient-AVA, or speculated mortality. When AVA was evaluated with CT (\<1.2 cm) and Echo (\<1.0 cm), larger cut-point values might be a valuable parameter in severe AS diagnosis ([@B22]). Fusion imaging might provide a more accurate assessment of the "true" AVA by decreasing the rate of discordant AS with low gradient but increasing the rate of discordant AS with high gradient ([@B3]). In clinical, it is crucial to accurately diagnose the severity of AS with the help of routine doppler because of characteristics of multiple imaging windows ([@B140]). Ejection dynamics, particularly acceleration time (AT) and the ratio of AT to ejection time (ET), could be applied to evaluate AS severity ([@B45]). In addition, doppler ultrasonography was used to evaluate transvalvular pressure drop using the simplified Bernoulli formulation to measure the severity of AS. Recently, a formulation that is corrected to calculate the cross-sectional profile of blood flow was used to estimate peak pressure drops accurately ([@B30]). Cardiac computed tomography could be recommended in younger BAV patients could with higher sensitivity and specificity. Although valvular calcification of the BAV had a faster progress in younger patients, there might be a hemodynamically significant stenosis without aortic valve calcification ([@B129]). As WSS is important in evaluating viscous shear forces on vessel wall due to abnormal flowing blood. 4-dimensional (4D) flow MRI measured volumetric velocity vector fields which could represent the increased regional WSS ([@B33]). Increased WSS in bicuspid AS patients distributed mainly along the ascending aorta, especially at the outer curvature. This was consistent with the fact that aortic dilatation in BAV patients was asymmetrically. The degree of elevated WSS was negatively related to aortic diameters. Therefore, in BAV patients, the elevated WSS of the ascending aorta was related to aortic valve stenosis and aortic dilatation, which was more obviously when patients manifested as AS and nondilated ascending aorta ([@B40]). If decomposed the WSS vector field into its axial and circumferential components (WSSA and WSSC) from 4D flow MRI data using a Laplacian approach, the average WSSC in the ascending aorta was statistically significant difference as a parameter for evaluating multidirectional flow in complex geometries ([@B135]).

In recent years, the proportion of bicuspid aortic stenosis patients who has been carried out TAVR is increasing with a tendency to younger patients. However, TAVR might meet different procedural changes. For Sievers type 0 patients with no raphe, the challenge might be an ellipse aortic annulus than a circle and the risk for paravalvular leakage. LR BAV patients might confront with the risk of imprecise allocation, due to the calcified raphe which placed unequal stress on the dilatation of a TAVR ([@B9]). In respect of procedural threat of TAVR, the new generation devices including ballon-expandable Sapien 3 and Lotus valve could overcome the crucial limitation of previous devices such as obvious perivalvular leak, failure to get optimal positioning and associated vascular complications ([@B97]; [@B158]; [@B116]; [@B161], [@B160]; [@B127]). Transcatheter balloon aortic valvuloplasty was considered palliative therapy for BAV as well as a useful tool in sizing ascending aorta. Currently operators used a median effective final balloon to aortic valve annulus ratio of 0.94 as criterion ([@B13]). However, the optimal approach for sizing in bicuspid aortic stenosis was controversial. Some recommended perimeter/area at the annulus level as criterion, and the others suggested to use the commissural level above the annulus about 4--8 mm as the sizing selection ([@B9]). To date, TAVR with the help of the new-generation device is a reasonable treatment option with the good outcome and low complication rate for bicuspid AS patients.

Aortic Regurgitation: Different Surgical Interventions
======================================================

Aortic regurgitation is more frequent in the earlier period of patient's life than stenosis ([@B107]). Once aortic regurgitation is formed, the major factor affecting the development is left ventricular pathological change due to chronic volume overload. As a result, surgical intervention will be the final decision for most bicuspid AR patients ([@B16]). We have a brief introduction including an assessment of degree of bicuspid AR and left ventricular function and different surgical interventions.

Transthoracic echocardiography is a preferred imaging test for evaluating bicuspid AR patients and guiding appropriate management decisions. Cardiac catheterization might be a valuable method to evaluate abnormal hemodynamics, anatomical structure of coronary artery and development of aortic regurgitation ([@B104]). Eccentric jet was common in BAV valve malformation, and it was difficult to accurately assess bicuspid AR with ultrasound. When eccentric jet was hard to be quantified and LV dilation was disproportionate to the degree of AR, cardiac MR might give a better way to quantity AR and LV volumes ([@B96]). In a study on the character of speckle-tracking echocardiography in terms of judgment cardiac function, assessment of circumferential as well as longitudinal strains was important. For asymptomatic patients with hemodynamically significant bicuspid AR, global circumferential strain (GCS) and global longitudinal strain (GLS) were lower compared with healthy. GCS compensated for the reduced GLS to ensure that global function and left ventricular ejection fraction (LVEF) remained in the normal range. However, the study showed no association between LVEF and GLS, whereas GCS was correlated with LVEF ([@B17]).

The majority of patients would require AVR, exception of severe AR with LVEF ≥ 50%, LVESD ≤ 50 mm, LVEDD ≤ 65 mm or progressive AR without other cardiac surgery. The most frequent valve-related complication leading to re-operation had been recurrence of AR induced by dilatation of the aortic root. For mild bicuspid BAV patients with aortic root dilation (\>40 mm) during their initial AVR procedure, the surgical intervention could be considered to decrease the incidence of recurrent AR ([@B48]). If the regurgitation BAV patient combines with annular dilatation, the repair treatment might not be successful. Sub-commissural annuloplasty resulted in earlier repair failures compared with complete circumferential annuloplasty ([@B99]; [@B100]). Suture annuloplasty with polytetrafluorethylene as material could eliminated annular dilatation and reduce local complications and tissue trauma. Suture annuloplasty should be considered whenever basal diameter exceeds 26--27 mm. The stability could be comparable to valve preserving aortic root replacement without the associated complexity of the procedure. After aortic valve repair, the height of coaptation was considered acceptable if vena contracta was ≥4 mm on TEE ([@B128]). Valve-sparing aortic root replacement (VSSR) could be a promising option for aortic regurgitation patients, which might improve repair durability, especially annulus stabilization, and should be recommended in young patients ([@B73]).

Infective Endocarditis: Antibiotic Prophylaxis Comes First
==========================================================

BAV patients were more likely to have infective endocarditis (IE) than the others ([@B134]). The majority of BAV with IE were men. Adverse events of IE included heart failure, peripheral embolism, embolic stroke, persistent bacteremia, and intracardiac complications ([@B20]; [@B166]).

The most common organisms causing IE were microorganisms presented in the oral cavity, mainly viridians group streptococci. BAV should be considered as high-risk cardiac conditions with unrestricted IE antibiotic prophylaxis ([@B20]). The signs of IE in TTE performance included vegetation, valvular perforation, and perivalvular abscess. There were no significant differences among left atrial diameter (LAD), left ventricular end-diastolic diameter (LVEDD), and left ventricular end-systolic diameter (LVESD) values like the incidences of serious AR or AS. Given the high frequency of perivalvular abscesses in BAV IE patients, systematic use of TTE or TEE in all BAV IE patients and prompt diagnosis of perivalvular abscesses are necessary and advantageous for the prognosis ([@B21]). In order to treat infection and avoid the sequelae resulting from tissue destruction of valve and paravalvular, surgical intervention was recommended, especially at early stage. To date, there was few long-term in multicentric follow-up study for BAV patients with infective endocarditis to verify the rationality of the current guidelines. For patients with BAV, cardiac echocardiography should be taken regularly to prevent the disease before getting worse.

Left Ventricle Dysfunction: Important but Unclear Relationship With BAV
=======================================================================

Under the presence of abnormal hemodynamics and aberrant gene expressions like TGF-β, NOTCH and MMPs, it might affect left ventricular function and lead to LV remodeling including myocardial hypertrophy and fibrosis. Although we did not have clear understanding about the relationship between BAV and myocardial hypertrophy, the data has showed that 0.9% of the HCM patients suffered from BAV and 0.4% of BAV patients were coexistent with HCM. 11 patients developed into dynamic obstruction, which always affect the LVOT. Resting obstruction was presented in five patients, which presented the gradient ± 30 mmHg ([@B112]). Collagen volume fraction (CVF) was reduced in sub endocardium and increased in endocardium. This might imply endocardial fibrosis in severe AS and AS was one of major complications of BAV as mentioned before. We speculate that endocardial fibrosis might exist in part of BAV patients ([@B142]). Late gadolinium enhancement (LGE) on MRI imaging has been used to identify the presence, pattern, and size of fibrosis as well as myocardial and cardiomyopathy ([@B2]; [@B46]). In a retrospective study with 29 BAV patients, CMR and TTE images were reviewed. Patients with LGE had significantly higher aortic valve mean gradients by TTE and were more likely to have LV hypertrophy. They were more likely to need aortic valve replacement within 1 year. Evaluation of LGE by CMR as a marker of LV myocardial fibrosis could have additional prognostic value ([@B82]). CMR is a non-invasive approach used to measure LV mass and volume and a valuable tool used to describe the LV remodeling in response to AS, which is regarded as a gold standard. BAV patients were demonstrated to have significantly larger left ventricular outflow tract dimensions (LVOTd), systolic LV area, LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV). The LVOTd is significant related with maximal aortic root diameters at all levels in BAV patients, especially with the aortic annulus diameter. But the correlation between LVOTd and mid-ascending aortic diameter was weak ([@B29]). The blood flow is strong eccentricity, which is presented in all degrees of AS. Alteration in poststenotic blood flow when AS is presented is the reason for elevating LV after load. The relationship between LV remodeling and aortic orifice area (AOA) emphasizes the notion that remodeling is a characteristic of all degrees of AS. The intensity of abnormal blood flow increases with the decreasing of AOA, and increases further with the presence of BAV. In addition to AOA, it is suggested that the flow parameter normalized flow displacement is an alternative sign for defective blood transporting and eccentric myocardial stress because it is in connection with LV remodeling. Different grades of AS were involved in elevated and asymmetrical WSS distribution. However, there is no correlation between it and LV remodeling. And the mechanotransduction risks of poststenotic dilatation should be paid more attention as it might happen in early period of AS ([@B145]). The mass index and indexed volumes of LV or the ratio of LV mass/volume are always measured to explore the extent and patterns of hypertrophy. A specific wall thickening of the myocardial, no less than 13 mm or 1.5 times larger than the opposing one, is regarded as asymmetric remodeling and hypertrophy. There are as many as six patterns of LV adaption including normal ventricular, concentric remodeling, asymmetric remodeling, concentric hypertrophy, asymmetric hypertrophy and LV decompensation. Despite unstable, the increased stress of LV still could cause extensive LV impairment ([@B32]). TTE is used to assess the systolic longitudinal strain which is a valuable indication to early LV disorder of AS. Decreasing in LV ejection fraction indicates that the LV dysfunction is stepping into the late stage ([@B101]; [@B119]). However, there seems to be no significant correlation between pattern of LV adaption or degree of hypertrophy and BAV classification. Although the women BAV patients were more likely to have aortic stenosis, there was no significant differences in sex regarding left ventricular function assessed by cardiac MRI ([@B32]).

In some BAV patients without aortic valve dysfunction and ascending aortic dilatation, cardiovascular MR tissue tracking imaging has demonstrated that ascending aortic and LV systolic and diastolic myocardial mechanics in all the three vectors (longitudinal, circumferential, and radial) are significantly impaired. The aortic valve congenital abnormality seems to be the only reason to cause LV impairment. That is to say, BAV may be not only a disease of aortic valve and aortic wall but also an inherent disease of the LV myocardium. This is a compelling evidence that the remodeling process of LV is associated with BAV, which has been debated for long ([@B106]). For asymptomatic BAV patients with preserved EF, feature-tracking CMR (CMR-FT) may be a useful and practical tool for assessing LV function. The impaired diastolic function caused by myocardial hypertrophy and fibrosis precedes systolic abnormalities and could predict the outcomes of surgical in patients with aortic stenosis. In asymptomatic BAV patients who have no signs of ventricular dysfunction by routine cardiac MRI, CMR-FT strain analysis can detect myocardial dysfunction especially when the diastolic strain rate decreased. With the improvement of surgery and diagnosis which could identify patients at younger age, the survival time of post-surgery patients has been extended. But continues monitoring LV function is still necessary. More attention should be paid to changes about cardiac structure and function to prevent LV dysfunction.

BAV-Associated Aortopathy: More Criterion About Assessment and Treatment Should Be Included Expect for Aortic Diameter
======================================================================================================================

The BAV-associated aortopathy has a prevalence of 40% in patients of multiple clinical centers. In contrast to general population, BAV patients were 86 times to develop proximal aortic aneurysms and 8 times to have aortic dissection. The morbidity of aortic dissection and rupture were about 0.4% during 2--16 years. The proportion of aortic rupture was very low, which there is only one rupture in all 14 cases in a 32 months follow-up ([@B94]; [@B71]; [@B88]). Cardiac cyst originated from bicuspid aortic valve was an extremely rare type of cardiac mass ([@B52]).

Aortic Dilatation: the Onset of BAV-Associated Aortopathy
=========================================================

Currently, there are two main theories on the relation between BAV and aortic dilatation: an underlying genetic substrate and hemodynamics theory. Gene mutations as mentioned above could not only causing the development of BAV but also exacerbating calcium deposition on the valve. The activity of MMPs is increased and fibrillin-1 expression is decreased in the wall of ascending aorta ([@B98]). Gradually, decreased collagen, increased elastic fragmentation, and reduced VSMCs in aortic middle layer degeneration lead to aortic convex surface before ascending aortic dilatation. And abnormal hemodynamics inside the ascending aortic will also cause uneven shear stress on the same area ([@B24]). This has a promotional effect in increasing expression of MMPs and VSMC apoptosis ([@B79]). And a stronger hemodynamic influence might play an important role in BAV patients who have tubular and stiff ascending aortic dilation ([@B159]). Not the stiffness index of all the aortic segments was higher than healthy. After adjusting the age and the aortic diameter, the sinus of Valsalva appeared to be the only segment significantly stiffer, which might suggest a local remodeling process in BAV patients ([@B51]).

Aortic dilatation with BAV was classified as three types: type 1 was dilatation of root, ascending and proximal arch aorta dilation along convexity of aorta. Type 2 was relative normal root with tubular ascending aorta dilation. Type 3 was isolated dilatation of aortic root alone ([@B144]). The location of aorta dilation was related to valve morphology, sex and bicuspid valvulopathy. RN-BAVs and RL-BAVs would induce dilation of different aortic part, which the dilation induced by RN-BAVs was located in ascending aorta, whereas the one induced by RL-BAVs was aortic root ([@B126]; [@B76]). AR could result in diffuse enlargement including annular, sinus of Valsalva, and ascending aortic, whereas AS of moderate to severe grade only led to ascending aortic enlargement. The diameter of sinus of Valsalva was larger in men when compared with women, whereas ascending aortic diameters were comparable ([@B125]). In addition, abnormal ratio of ascending aortic area/height, as well as sinus of Valsalva and ascending aortic dilatation rate might be regarded as predictors of cardiovascular death ([@B28]; [@B89]).

2D TTE is a feasible, accurate, and reproducible method for the non-invasive assessment of thoracic aortic diameters. It has been reported that unbiased agreement could be obtained between the CTA inner edge--to--inner edge method and TTE leading edge--to--leading edge method for the sinuses and ascending aortic ([@B114]). Aortic WSS correlated with regional elastic fiber thinning was heterogeneous within the aorta of an individual patient with BAV. The association between WSS and regional histopathology was the most closely, which predominant manifested as AS and mildly aortic dilation (\<4.5 cm) ([@B6]; [@B14]).

After repeated modifications in different international guidelines on BAV aortopathy, AAR (ascending aorta replacement) might be a suitable option for patients with severe AS or AR who have suffered AVR, when diameter of aorta was \>4.5 cm ([@B57]; [@B103]). When the situation that the dilation of aortas reaches 5.1--5.5 cm and aortic dissection or aortic growth rate ≥ 0.5 cm per year is presented in family history, aortic repair operation could be recommended ([@B57]). Mid-term imaging after AVR and AAR indicated that prophylactic root replacement will be unnecessary in case that aortic root is not dilated in surgery, because of unlikely aortic root enlargement later in patients ([@B58]).

Aortic Aneurysm and Dissection: Need More Predictors and Timely Recognition
===========================================================================

Once aortic dilation was suspected, the entire aorta and affected parts which should be considered to be at risk for aortic aneurysm or dissection. Although aorta diameter ≥40 mm was considered to be aortic dilation in the 2014 AHA guideline, risk of aortic dissection was significantly correlated with the aortic diameter. The estimated risk of aortic dissection gradually increases when diameter of the aorta becomes larger ([@B71]).

Due to aorta dynamic change with the heart contraction and diastole, aortic size alone was not enough to distinguish different pathological processes under the risk of acute complications. Other predictors about aortic wall and blood flow changes could be developed to assess the timing of surgical intervention ([@B10]). Wall shear stress, flow displacement and helicity were elevated in patients with BAV, particularly at locations of aneurysm formation ([@B11]; [@B162]). The anterior region of ascending aortic aneurysm sample (the zone with lower curvature) was the most weakness and less stiff, resulting in the ascending aortic aneurysm expansion in such a region ([@B41]). This might provide the possible reason that patients with aortic diameter whose size do not meet surgical criteria are prone to acute aortic rupture or dissection. 4D flow MRI seemed to be a useful tool showing biphasic trend followed by dilated diameter of aneurysm. With the diameter of ascending aortic enlarged, it decreased firstly and increased. This curve has an obvious turning point as the diameter of ascending aortic was 50 mm ([@B53]). The single diameter of aortic root or ascending aortic should not be used as a basis for the possible formation of aortic dissection. The cross-sectional area to height ratio and patient -- specific aneurysm wall stress analysis were recommended to predict aortic dissection ([@B151]; [@B57]; [@B154]). European and American guidelines for intervention for BAV aortic aneurysms are not consistent. In ESC guideline, interventions should be recommended for patients with ascending aortic diameter ≥50 mm and risk factors ([@B37]; [@B60]). In American guidelines, for patients of BAV, the diameter of ascending aortic or sinus is larger than 5.5 cm, surgical repair should be assessed and recommended ([@B56]).

As BAV with aortic aneurysm could progress to aortic dissections, timely recognition of aneurysm can be lifesaving due to the high mortality rate ([@B39]). Young adults were better treated with reimplantation of the aortic valve, as correction of annular dilation was important. The closer 2 main commissures are to 180°, the better the long-term results will be ([@B26]). For some young patients, the aortic cusps are nearly normal anatomically and morphologically, aortic valve-sparing root replacement was also an effective alternative ([@B109]). In contrast, recent study provided that valve-sparing root replacement and bio-composite valve led to equivalent operative mortality and morbidity with similar midterm survival and valve durability ([@B38]). In emergency situation, aortic valve replacement could be performed to AD patients ([@B36],[@B37]). Aortic valve resuspension with supra-coronary aortic replacement could be recommended to restore aortic valve competency in most AD patients with acceptable mid-term survival ([@B139]).

Pediatric BAV: Cannot Apply Adult Knowledge
===========================================

Pediatric BAV, although similar to adult BAV, has different characteristics in disease development and treatment. According to Sievers classification, BAV morphology including type 0 (55%), type 1 (41%), and type 2 (4%) in children ([@B93]). At an early stage, some children with well-functioning BAV have abnormalities in some parameters of diastolic function of LV and even all parameters of proximal and distal ascending aortic elasticity. However, there is no relationship between the aortic stiffness and LV diastolic impairment ([@B150]). *Z*-scores of children seem higher at the site of annulus, sinus valsalva, sinutubular junction, and ascending aorta. Moreover, the aortas start to enlarge in BAV patients from childhood and progress as time goes on, 0.06 (Gautier) and 0.09 (Campens) units per year at the age of 5--15 years, which delivers us a signal that generalized aortopathy has come around. The elasticity of aortas increases at young age and begins to decrease with age ([@B144]). In some pediatric patients with BAV, aortic growth is not proportional to body growth. The sizes of sinuses of Valsalva or ascending aorta seems to be larger, which might be associated with AR or AS. BAV morphology is a important factor that could directly affect the dilation of aortic sinus. Although the dilation of aortic sinus is not existing patients who manifests as RN fusion morphology, the median *Z* score of aortic sinus is significantly higher in these who have RL fusion morphology, which is keeping in accordance with some conclusions obtained from adults ([@B62]; [@B70]). And the RN fusion morphology is associated with significantly greater incidence and undesirable prognosis of aortic valve stenosis and aortic insufficiency in contrast to ascending aorta ([@B149]).

For the patient with isolated, normal functioning BAV, echocardiography could be used to monitor development of BAV associated complications ([@B93]). Due to the inaccuracy in measurement of aortic valve annular eccentricity through 2D echocardiography, therefore, 3D echocardiography could be a better choice to evaluate the AV annulus which has the shape of ellipse and keeps the same in all patients ([@B19]). On the contrary to adult patients, WSS seems to be not related to ascending aortic dilation in pediatric BAV patients after the valvular disease being controlled. The enlarging of aorta diameters causing the reduction of WSS, which takes place in adult BAV, will keep a long time and seems to be scarcely in pediatric BAV patients ([@B1]). Echocardiographic endpoints are measured as *z*-score, which manifests as progressive AS or AR and aortic enlargement at different levels of the aortic root. It is benign in the period of medium-term follow-up. It is suggested that the degree of AS was constant in 95% of patients and about 85% of the patients showed no increase in the degree of AR. Although the ascending aorta dilation was observed (*z*-score \>2) and the incidence was less than one-fifth of the patients, the progressive dilation was not existed in annulus, Valsalva sinuses, or sinotubular junction ([@B136]).

Stenosis is the dominating clinical feature in younger patients and regurgitant becomes predominant when patients are stepping into adulthood. It has been suggested that regurgitant valves are always accompany with stenotic parts that is the result of commissural fusion, which restricts the motion of the leaflet in pediatric patients ([@B130]). There are six types of the dilated aorta in children with BAV including the normal shape (S1), the enlarged ascending aorta (S2), the effacement of the sinotubular ridge (S3), the Marfan-like (S4), the enlarged sinus of Valsalva and ascending aorta (S5), the normal annulus, and proximal sinus of Valsalva, enlarged distal sinus of Valsalva, sinotubular ridge, and ascending aorta (S6). S2 and S3 are more presented than other types. S3 becomes the dominating type with aortic dilation becoming more significant. Although some patients with S2 or S3 BAV shape have no aortic dilation, the ascending aorta was larger compared with normal aorta, which also suggested that the process of abnormal dilation might have already begun ([@B87]).

The effect of surgical repair in pediatric BAV patients is excellent, especially no patches are attached. The primary repair is recommended because enduring results can be obtained with simple procedures. It is suggested that some patients underwent the surgery of bicuspid valve repairment without addition any patch material and there is no adverse events for up to 10 years because the valves used in the surgery is similar to the native valves. Up to now, compared with an extensive debridement of the valve, it is hard to identify the patients who will have a better prognosis. The ross procedure is recommended to carry out in adult age because a quarter of the patients need to replace their autografts within 2 decades, which we hope to create a situation that the root of autograft is reinforced more easily ([@B130]). Aortic incompetence (AI) is the main reason for aortic valve balloon valvuloplasty surgery after BAV ([@B5]). The degree of AI is closely related to the ratio of balloon/annulus, but not related to the valve morphology. Balloon valvuloplasty is associated with the decreasing mortality and could reduce acute postoperative complications, which root in the decreasing ratio of balloon/annulus that is a well-known risk factor to increase the acute complications ([@B72]).

Marfan and Loeys-Dietz Syndrome: Similar With the Ascending Aortic Dilatation in BAV
====================================================================================

Bicuspid aortic valve with aortic dilation should be distinguished from other symptom-similar diseases, such as Loeys--Dietz syndrome and Marfan syndrome. The syndrome of Marfan is characterized by heritable connective tissue lesion caused by the mutation of FBN1 gene among 90% patients and involved in multiple organs including cardiac and valve ([@B7]). Marfan syndrome has the higher risk of dissection and recurrent aneurysm than BAV with aortic dilation. For patients who have haploinsufficient FBN1 mutations, angiotensin II receptor inhibitor might reduce aortic root dilatation rate ([@B43]). β-Blockers is used to reduce the aortic dilation and improve the rate of survival ([@B35]). It has been suggested that patients need to have surgery when the maximal diameter of aortic root is more than 50 mm or other parts of the aorta \>50 mm or dilation is progressive according to ESC guidelines that about the management of congenital heart disease in adult patients. In some cases, although the aortic root diameter of patients is between 46 and 50 mm, not reaching the criterion 50 mm, they still need surgery because of progressive dilation \> 2 mm/year ([@B7]; [@B36],[@B37]). And the JCS guideline recommend a more rigid criterion for surgery, maximal aortic diameter ≥45 mm or \>40 mm but with positive family history ([@B65]). When Marfan syndrome and pregnancy are co-occurrences in one women, it is suggested to make the root part of the aorta and ascending aorta replaced if the diameter \> 40 mm according to AHA; however, the aortic root aneurysm ≥45 mm is the criterion for surgery according to ESC ([@B56]). It is critical to perform the surgery with the experienced hands, which could reduce the risk of combining aortic valve and ascending aorta replacement ([@B50]). Valve-sparing operations or remodeling of the aortic root should be taken into consideration if the valves with normal anatomically ([@B66]).

Few BAV patients were identified in Marfan syndrome patients. According to a study regarding association of Marfan syndrome and BAV, it is demonstrated that the association between the two disorders seems to cause a higher percentage of thoracic aortic aneurysm requiring surgical intervention ([@B105]).

Loeys--Dietz syndrome, an autosomal-dominant connective tissue disorder, has different types based on gene mutations in the TGFBR1 (type 1), TGFBR2 (type 2), SMAD3 (type 3), and TGFB2 (type 4) ([@B85]). Loeys--Dietz syndrome has the characteristics of rapidly progressive aortic aneurysm and aortic dissection and cerebral hemorrhages are major causes of death ([@B83]). Hence, echocardiography monitoring is recommended as a useful diagnosis method to this syndrome ([@B143]). If some variations are observed including aortic root dimension \>40 mm or the expansion of aortic root \>0.5 cm over 1 year or the dimensions of the ascending aorta \>40 mm in adults and aortic annulus is 20--22 mm or the expansion of aorta \> 0.5 cm over 1 year or severe craniofacial features or positive family history about aggressive aortic disease in children, it is time for surgical intervention ([@B123]). In American guideline, the aorta need to be repaired in these situations including BAV with Loeys--Dietz syndrome, the diameter of aorta \> 4.2 cm by transoesophageal echocardiogram (internal diameter) with mutations in TGFBR1 or TGFBR2 or the external diameter \> 4.4 cm by CT or MRI ([@B56]).

The surgery of valve-sparing seems to be prohibited in the situation of extensive calcification or dysfunction in BAV patients ([@B68]). But the replacement surgery of valve-sparing aortic root could be recommended in experienced hands for children ([@B23]). It is necessary to perform the aortic root repair surgery when the maximal dimension of aortic root reaches 40 mm in adults with LDS type 1 or 2 ([@B85]). So far, there is no clear and comprehensive guideline to introduce the therapy on Loeys--Dietz syndrome.

New Technique: Developing Minimally Invasive Technique
======================================================

Many of the aortic valve replacements used clinically are not alive and ROSS procedure is an exception. In order to preserve the anatomical and functional integrity of the aortic root, ROSS procedure utilizes pulmonary autograft instead of lesions aortic valve ([@B91]). ROSS procedure has good hemodynamic performance during activity and the lower gradient of normal aortic valve function at rest ([@B121]). Patients who undergo ROSS surgery have a higher quality of life than patients who undergo mechanical valves ([@B163]). ROSS has been improved in past several decades. At first, pulmonary autograft transplantation with the sub coronary and root replacement techniques translated into a full root replacement technique ([@B132]). To prevent from postoperative expansion, prosthetic Dacron graft could be used to strengthening the pulmonary autograft ([@B18]). However, ROSS procedure has not been adopted worldwide with underlying reasons as operative risk and technical complexity. As a result, it increases possible failure of valves stability for long and complexity of the second intervention surgery ([@B122]). ROSS procedure is more suitable for younger patients or middle-aged (\<50 years old) patients or prosthetic AVR in young patients with aortic insufficiency ([@B108]). 85% of BAV patients, whose median age is 40 years old, could be freedom from reoperation at 20 years with a follow-up of 9 years ([@B120]).

In spite of valve replacement is standard therapy now, BAV patients with normal cusps might be recommended to have valve repair ([@B164]). For young patients, the aortic annulus does not match the adult-sized prosthesis and need normal root structure to grow. Hence, it is necessary to retain native aortic root in valve repair operation. Although cusp extension has no newer techniques, it seems unlikely to be avoided for young people as a part of aortic valve repair. Compared with BAV repair in children with median age 12.6 years by tricuspidization with cusp extension (TCE), the stability of valve function after ROSS procedure seems to be higher ([@B92]). The other repair techniques used in the past have commissural suture, cusp procedures and aortic root procedures. The cusp procedures contain cusp resection, patching, commissurotomy, debridement and free-margin plication. The aortic root procedures include root remodeling, resuspension and reimplantation. Recently, figure-of-8 suspensory sutures (Svensson) or Cabrol commissuroplasty are carried out in aortic valve repair. The point of suspensory sutures in Svensson operation is the lip of cusps at 3--4 mm above the commissure ([@B59]). The latter is plication at center and 2 commissural stitches. Compare the outcomes of these techniques, Svensson technique has lower rate of reoperation and better durability for long, as well as valve resuspension, root repair and replacement ([@B138]). However, some of cusp repair procedures such as commissuroplasty, commissural sutures and plication might be related to higher rate of reoperation ([@B61]). Kari technique could correct prolapse combined with valve-sparing aortic root replacement and cusp repair. 90% of the patients avoided reoperation at 6 years and 100% avoided higher than grade 2 aortic regurgitation ([@B67]).

Ozaki technique was first reported in 2014 and use autologous pericardium to replace tricuspid. The pericardial cusp was excised at least 7 cm × 8 cm, and was sutured to the annulus ([@B110]). In 850 patients with average age of 71 years who have undergone Ozaki technique, 85.9% have the second operation, 4.2% have moderate AR and nobody had additional valve replacement. There was no conversion to a prosthetic valve replacement. The midterm outcome seemed to be satisfactory ([@B124]). For younger patients, Ozaki technique might have an advantage because it required only Aspirin, rather than antivitamin K. The other one was that it did not need enlarge aortic root for patients with small annulus. Given the benefits of Ozaki technique, minimally Invasive Ozaki's Procedure was carried out in nine patients. First, the minimally invasive procedure could provide clear surgical field by smaller incision to collect pericardium and reduce damage to the heart or risk of hemostasis. In addition, patients could be freedom from ventilation earlier, reduce ICU and hospital stay after operation. Thus, upper ministernotomy combined with Ozaki procedure might be a feasible approach instead of full sternotomy ([@B102]). However, Ozaki technique or combined ministernotomy require longer follow-up outcomes in young adults.

Future Directions
=================

Bicuspid aortic valve is a general geneogenous heart defects and burden from BAV is more significant than other congenital cardiac lesions around the word. Despite many emerging studies focus on the pathogenesis, diagnosis and treatment of BAV as shown in [Figure 2](#F2){ref-type="fig"}, our understanding of the disease is still incomplete and many questions remain need to be illuminated in future studies.

![For better understanding the problems involved in bicuspid aortic valve, a clear diagram was provided. In general, it includes the etiology (morphology and abnormal hemodynamics described in complication section), diagnosis (imaging, biomarker and genetic diagnosis), treatment (medicine and surgical treatment), and various complications involved in bicuspid aortic valve.](fphys-09-01921-g002){#F2}

Gene mutations polymorphism and aberrant changes in hemodynamics have been thought to be the two main aspects of BAV pathogenesis. Although it has been reported that many genes and cellular signaling pathway were involved in malformations of valves, none has been confirmed to play central role. This restricts the clinical translational applications of research findings to patients timely. Hemodynamics which is affected by malformations of the valves, might not be reversed by preventive surgical intervention. To date, it is necessary to perfume early biomarkers test and multiple imaging diagnosis including ultrasound, cardiac CT and 4D MRI. Although given the weight of evidence about aberrant biomarkers in BAV patients, it still needs to be clarified the importance of these biomarkers when they are appeared in patients' samples. Besides, the relationship between these biomarkers and severity or prognosis of BAV need to be explored further. Therefore, specificity and sensibility of biomarkers are relative insufficiency, and could not provide accurate information for doctors. Combined imaging diagnosis seems to be the only effective method to evaluate valve morphology, function, hemodynamics and complications, which present evidence for timely surgical intervention.

Although medicine treatment has not achieved obvious effect in BAV patients, gene targeted delivery or therapy might be a promising treatment to prevent BAV and its complications according to widely genetic research. So far, surgical intervention is the only efficient way in the management of patients. The threshold of surgery, aortic diameter, has been modified repeatedly in the international guidelines, but it is inadequate to draw a perfect heal scheme. Although aortic valve replacement is the major surgical therapy recently, other surgical techniques still need to be explored and tried. It would be better if they could be combined with invasive techniques in the future. Since the development of BAV is affected by multiple factors as mentioned before, optimal surgical intervention and comprehensive treatment options should be individualized to the patients in the future.
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